Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1979-05-15
1980-12-02
Schankman, Leonard
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
424312, 424313, 424314, 424316, A61K 3132
Patent
active
042371678
ABSTRACT:
A therapeutical method for treating uraemic patients in regular dialysis treatment (RDT) is disclosed, wherein an acyl-carnitine (typically acetyl-carnitine) is administered to the patients. The acyl-carnitine can be administered over the whole treatment period by the oral route exclusively. Alternatively, while oral administration is carried out in those days in which the patient is not subjected to the haemodialytic session, when the patient undergoes dialysis, the acyl-carnitine is administered by slow infusion, or an acyl-carnitine-containing dialyzing liquid is used. Furthermore, a suitable dialyzing solution is also disclosed.
REFERENCES:
Lancet, Apr. 21, 1979, p. 882.
Chemical Abstracts, 86:137401b, (1977).
Chemical Abstracts, 83:73716m, (1975).
Chemical Abstracts, 82:166032e, (1975).
Horwitz Lester
Schankman Leonard
LandOfFree
Acyl-carnitines in a therapeutical method for treating chronic u does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Acyl-carnitines in a therapeutical method for treating chronic u, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acyl-carnitines in a therapeutical method for treating chronic u will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2284168